J&J's Taubert to retire; Tom Cavanaugh named EVP of Innovative Medicine
Johnson & Johnson announced Executive Vice President Jennifer Taubert will retire on September 1 after 21 years leading the $60B Innovative Medicine unit. Tom Cavanaugh is appointed to succeed her as EVP, Worldwide Chairman of the business.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day